Experience

Shionogi & Co., Ltd

• Pharmaceutical Manufacturing
• 200 - 300 Employee

• Chief Medical Officer

  • Jul 2022 - Present

• Global Head of Medical Science

  • Oct 2019 - Jul 2022



Roche

• Switzerland
• Biotechnology Research
• 700 & Above Employee

• Translational Medicine Leader, Neuroscience and Rare Diseases

  • Mar 2019 - Oct 2019

• Life Cycle Leader, Neuroscience

  • Mar 2017 - Mar 2019



Eli Lilly and Company

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Brand Development Leader, Pain & Biomedicines Core Therapeutics

  • Feb 2017 - Mar 2017

• Vice President Product Development & Medical Affairs, Emerging Markets

  • Mar 2014 - Jan 2017

• Drug development leader, Psychiatry & Pain

  • Oct 2012 - Feb 2014

  Head of late phase drug development for Lilly´s portfolio in the areas of psychiatry and pain disorders.

• Senior Medical Director, Global Drug Development for Psychotic Disorders

  • May 2009 - Oct 2012

• Senior Medical Director, Global Drug Development, Neuroscience

  • Apr 2009 - Oct 2012

  Scientific head of global drug development for Lilly´s late phase portfolio in schizophrenia, bipolar disorder and related diseases



Eli Lilly Japan

• Medical Director, Drug Development and Medical Affairs

  • Jun 2005 - Apr 2009

  Scientific leader for drug development and medical affairs activities of Lilly in Japan, across all therapeutic areas Scientific leader for drug development and medical affairs activities of Lilly in Japan, across all therapeutic areas


Master in Clinical and Pharmaceutical Research Program, Univerisity of Alcala
• Member of Scientific Board

  • Sep 2002 - Jun 2005

Fundación Lilly
• Spain
• Non-profit Organization Management
• Board Member

  • Jun 2001 - Jun 2005


Eli Lilly Spain

• Spain

• Country Medical Director

  • Sep 2000 - May 2005

  Head of Medical Affairs and Drug Development activities of Lilly in Spain across all therapeutic areas

• Clinical Research Physician, Neuroscience

  • Jan 1993 - Aug 2000

  Scientific leader for drug development and medical affairs project in Neuroscience area


Private Practice
• Professional Training and Coaching
• 1 - 100 Employee
• Psychiatrist

  • Jan 1993 - Dec 1997

Institute of Psychiatry, Psychology & Neuroscience
• Research Services
• 300 - 400 Employee
• Psychiatrist and researcher

  • Apr 1992 - Dec 1992

Hospital Clinico San Carlos
• Spain
• 1 - 100 Employee
• Psychiatrist

  • Apr 1989 - Dec 1992

Public service
• Denmark
• Design Services
• 1 - 100 Employee
• Primary Care Physician

  • Sep 1988 - Jun 1989